174 related articles for article (PubMed ID: 31012333)
1. Cost implications of adverse drug event-related emergency department visits - a multicenter study in South Korea.
Lee MS; Lee JY; Kang MG; Jung JW; Park HK; Park HK; Kim SH; Lee EK
Expert Rev Pharmacoecon Outcomes Res; 2020 Feb; 20(1):139-146. PubMed ID: 31012333
[No Abstract] [Full Text] [Related]
2. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.
Wu C; Bell CM; Wodchis WP
Drug Saf; 2012 Sep; 35(9):769-81. PubMed ID: 22823502
[TBL] [Abstract][Full Text] [Related]
3. Drug-related emergency department visits in an elderly veteran population.
Yee JL; Hasson NK; Schreiber DH
Ann Pharmacother; 2005 Dec; 39(12):1990-5. PubMed ID: 16288080
[TBL] [Abstract][Full Text] [Related]
4. Associated factors and costs of avoidable visits to the emergency department among cancer patients: 1-year experience in a tertiary care hospital in South Korea.
Oh TK; Jo YH; Choi JW
Support Care Cancer; 2018 Nov; 26(11):3671-3679. PubMed ID: 29740693
[TBL] [Abstract][Full Text] [Related]
5. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
6. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
[TBL] [Abstract][Full Text] [Related]
7. Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital.
Freitas GRM; Tramontina MY; Balbinotto G; Hughes DA; Heineck I
Value Health Reg Issues; 2017 Dec; 14():1-8. PubMed ID: 29254532
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.
Meier F; Maas R; Sonst A; Patapovas A; Müller F; Plank-Kiegele B; Pfistermeister B; Schöffski O; Bürkle T; Dormann H
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):176-86. PubMed ID: 24934134
[TBL] [Abstract][Full Text] [Related]
9. The cost of observation care for commercially insured patients visiting the emergency department.
Sabbatini AK; Wright B; Hall MK; Basu A
Am J Emerg Med; 2018 Sep; 36(9):1591-1596. PubMed ID: 29366657
[TBL] [Abstract][Full Text] [Related]
10. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
11. Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study.
Bennett K; Cahir C; Sorensen J
Eur J Clin Pharmacol; 2023 Oct; 79(10):1417-1424. PubMed ID: 37615688
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
13. Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety Communications.
Geller AI; Zhou EH; Budnitz DS; Lovegrove MC; Dal Pan GJ
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):352-356. PubMed ID: 32483401
[TBL] [Abstract][Full Text] [Related]
14. Adverse Drug Reactions (ADR) and Emergencies.
Schurig AM; Böhme M; Just KS; Scholl C; Dormann H; Plank-Kiegele B; Seufferlein T; Gräff I; Schwab M; Stingl JC
Dtsch Arztebl Int; 2018 Apr; 115(15):251-258. PubMed ID: 29735005
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study.
Patel KJ; Kedia MS; Bajpai D; Mehta SS; Kshirsagar NA; Gogtay NJ
BMC Clin Pharmacol; 2007 Jul; 7():8. PubMed ID: 17662147
[TBL] [Abstract][Full Text] [Related]
16. Emergency department visits caused by adverse drug reactions: results of aTurkish university hospital.
Girgin MC; Yanturali S; Arici MA; Çolak Oray N; Doylan Ö; Demiral Y; Tunçok Y
Turk J Med Sci; 2016 Jun; 46(4):945-52. PubMed ID: 27513388
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of drug hypersensitivity reactions using 6-year national health insurance claim data from Korea.
Han J; Ye YM; Lee S
Int J Clin Pharm; 2018 Oct; 40(5):1359-1371. PubMed ID: 29611015
[TBL] [Abstract][Full Text] [Related]
18. Cost evaluation of adverse drug reactions in hospitalized patients in Taiwan: A prospective, descriptive, observational study.
Chan AL; Lee HY; Ho CH; Cham TM; Lin SJ
Curr Ther Res Clin Exp; 2008 Apr; 69(2):118-29. PubMed ID: 24692791
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Costs for Acute Hospitalized and Chronic Heart Failure in South Korea: A Multi-Center Retrospective Cohort Study.
Ku H; Chung WJ; Lee HY; Yoo BS; Choi JO; Han SW; Jang J; Lee EK; Kang SM
Yonsei Med J; 2017 Sep; 58(5):944-953. PubMed ID: 28792137
[TBL] [Abstract][Full Text] [Related]
20. Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency Department.
Kiechle ES; McKenna CM; Carter H; Zeymo A; Gelfand BW; DeGeorge LM; Sauter DA; Mazer-Amirshahi M
J Med Toxicol; 2018 Dec; 14(4):272-277. PubMed ID: 29968185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
